CAH Valuation

Cardinal Health Inc

Add to Watchlist

Advanced Chart

157.140

-1.14(-0.720%)1D

Overview
Forecast
Valuation
Earnings

CAH Relative Valuation

CAH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CAH is overvalued; if below, it's undervalued.

Historical Valuation

Cardinal Health Inc (CAH) is now in the Overvalued zone, suggesting that its current forward PE ratio of 17.45 is considered Overvalued compared with the five-year average of 12.20. The fair price of Cardinal Health Inc (CAH) is between 96.76 to 132.99 according to relative valuation methord. Compared to the current price of 158.28 USD , Cardinal Health Inc is Overvalued By 19.02%.

Relative Value

Fair Zone

96.76-132.99

Current Price：158.28

19.02%

Overvalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

-12.80

P/B

Median3y

-10.04

Median5y

-3.95

6.47

FCF Yield

Median3y

11.06

Median5y

11.08

Competitors Valuation Multiple

The average P/S ratio for CAH's competitors is 0.58, providing a benchmark for relative valuation. Cardinal Health Inc Corp (CAH) exhibits a P/S ratio of 0.15, which is -73.51% above the industry average. Given its robust revenue growth of 0.02%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap